InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Marshall Fordyce, PRESIDENT AND CEO, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 30 open-market SEC Form 4 transactions: 0 purchases worth $0 and 30 sales worth $12.9M, reported from Aug 12, 22 to Jul 7, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | VERAVera Therapeutics, Inc. | SELL | 32.5K | $43.59 | $1.4M |
| Jun 23, 26 | VERAVera Therapeutics, Inc. | SELL | 18.4K | $38.43 | $698K |
| May 12, 26 | VERAVera Therapeutics, Inc. | SELL | 14.2K | $37.09 | $521K |
| Apr 14, 26 | VERAVera Therapeutics, Inc. | SELL | 14.1K | $45.51 | $617K |
| Feb 23, 26 | VERAVera Therapeutics, Inc. | SELL | 16.9K | $41.98 | $711K |
| Feb 26, 25 | VERAVera Therapeutics, Inc. | SELL | 8.0K | $28.32 | $220K |
| Feb 21, 25 | VERAVera Therapeutics, Inc. | SELL | 10.6K | $27.89 | $296K |
| Jan 8, 25 | VERAVera Therapeutics, Inc. | SELL | 10.0K | $42.03 | $414K |
| Dec 18, 24 | VERAVera Therapeutics, Inc. | SELL | 5.0K | $44.03 | $219K |
| Dec 11, 24 | VERAVera Therapeutics, Inc. | SELL | 14.9K | $47.65 | $700K |
| Nov 25, 24 | VERAVera Therapeutics, Inc. | SELL | 7.7K | $49.00 | $369K |
| Nov 13, 24 | VERAVera Therapeutics, Inc. | SELL | 12.2K | $51.20 | $605K |
| Oct 23, 24 | VERAVera Therapeutics, Inc. | SELL | 12.7K | $42.00 | $506K |
| Oct 9, 24 | VERAVera Therapeutics, Inc. | SELL | 12.3K | $38.83 | $467K |
| Sep 25, 24 | VERAVera Therapeutics, Inc. | SELL | 8.6K | $47.06 | $393K |
| Sep 11, 24 | VERAVera Therapeutics, Inc. | SELL | 9.3K | $37.78 | $346K |
| Aug 28, 24 | VERAVera Therapeutics, Inc. | SELL | 14.9K | $37.53 | $549K |
| Aug 21, 24 | VERAVera Therapeutics, Inc. | SELL | 14.5K | $39.76 | $575K |
| Aug 14, 24 | VERAVera Therapeutics, Inc. | SELL | 15.6K | $37.56 | $587K |
| Aug 21, 23 | VERAVera Therapeutics, Inc. | SELL | 5.2K | $16.66 | $87K |
| Oct 4, 22 | VERAVera Therapeutics, Inc. | SELL | 10.4K | $22.19 | $226K |
| Oct 3, 22 | VERAVera Therapeutics, Inc. | SELL | 11.4K | $21.16 | $232K |
| Sep 13, 22 | VERAVera Therapeutics, Inc. | SELL | 12.2K | $21.48 | $262K |
| Sep 12, 22 | VERAVera Therapeutics, Inc. | SELL | 12.8K | $21.07 | $263K |
| Sep 9, 22 | VERAVera Therapeutics, Inc. | SELL | 12.9K | $20.16 | $260K |
| Sep 8, 22 | VERAVera Therapeutics, Inc. | SELL | 15.1K | $20.52 | $310K |
| Sep 7, 22 | VERAVera Therapeutics, Inc. | SELL | 6.8K | $20.03 | $136K |
| Sep 2, 22 | VERAVera Therapeutics, Inc. | SELL | 9.8K | $21.50 | $210K |
| Sep 1, 22 | VERAVera Therapeutics, Inc. | SELL | 17.1K | $21.22 | $363K |
| Aug 12, 22 | VERAVera Therapeutics, Inc. | SELL | 20.5K | $20.16 | $414K |